Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Adriana Quero"'
Autor:
Edvan de Queiroz Crusoe, P. Cury, Vania Hungria, Ana Luiza Miranda Silva Dias, Fabiana Higashi, Adriana Quero, Renata Bacic Palhares, Flávia Fernandes Silva Zacchi
Publikováno v:
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy, Vol 42, Iss 2, Pp 159-163 (2020)
Hematology, Transfusion and Cell Therapy, Vol 42, Iss 2, Pp 159-163 (2020)
Background Bone marrow angiogenesis is increased in multiple myeloma (MM) patients, prompting the rationale for using antiangiogenic drugs in the treatment of these patients. Objective To assess angiogenesis in patients with MM at diagnosis and follo
Autor:
Manuella S.S. Almeida, Fabiana Higashi, Ana Lucia Peres, Eliana C M Miranda, José Carlos Barros, Edvan de Queiroz Crusoe, Vania Hungria, Maria Paula Nalesso Camargo Padilha, P. Cury, Adriana Quero, Carlos S. Chiattone
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Volume: 36, Issue: 1, Pages: 19-24, Published: JAN 2014
Revista Brasileira de Hematologia e Hemoterapia
Revista Brasileira de Hematologia e Hemoterapia v.36 n.1 2014
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
Revista Brasileira de Hematologia e Hemoterapia, Vol 36, Iss 1, Pp 19-24 (2014)
Revista Brasileira de Hematologia e Hemoterapia
Revista Brasileira de Hematologia e Hemoterapia v.36 n.1 2014
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
Revista Brasileira de Hematologia e Hemoterapia, Vol 36, Iss 1, Pp 19-24 (2014)
Background Induction therapy followed by high-dose chemotherapy and autologous transplantation is the standard treatment for suitable patients with multiple myeloma. Objective The aim of this study was to assess whether induction therapy with thalido
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc23f610ddbec14f720bc37ca6cb9224
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842014000100019&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842014000100019&lng=en&tlng=en
Autor:
Marcio Nucci, Vania Hungria, Gemoh, Esteban Braggio, Marcia Garnica, Gislaine Oliveira-Duarte, Eduardo Magalhães Rego, Adriana Quero, Carmino Antonio De Souza, Carmen Silvia Passos Lima, Irene Lorand-Metze, José Carlos Barros, Ana Lucia Peres, Carlos S. Chiattone, Roberto José Pessoa Magalhães, Paola Tanaka, Daniel Mercante, Ilana Zalcberg Renault, Luciana C.O. Oliveira, Eliana C M Miranda, Angelo Maiolino
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Despite the good response of stem cell transplant (SCT) in the treatment of multiple myeloma (MM), most patients relapse or do not achieve complete remission, suggesting that additional treatment is needed. We assessed the impact of thalidomide in ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13eef72551c6372cd4071f97bccdf223
Autor:
Sebastián Delgado, Maylett Uzcategui, Jorge Redondo, Lorena Suarez, Julio Flórez-López, Maria Eugenia Marante, Leandro León, Adriana Quero, Betsy Vera, Luis A. Núñez
Portal of damage: A web-based finite element program for the analysis of framed structures subjected to overloads (Marante, María E.; Suárez, Lorena; Quero, Adriana; Redondo, Jorge; Vera, Betsy; Uzcategui, Maylett; Delgado, Sebastián; León, Luis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42955f58b06555fb6cee987bbdd1559d
http://www.saber.ula.ve/handle/123456789/16910
http://www.saber.ula.ve/handle/123456789/16910
Autor:
Vânia Tietsche de Moraes Hungria, José Carlos Barros, Gislaine Oliveira Duarte, A Maiolino, E.M. Rego, Adriana Quero, AL Miguel-Perez, Esteban Braggio, Marisa R. Nucci, Rodrigo Magalhães, E.C.M. Miranda, Daniel Mercante, Irene Lorand Metze, C.A. De Souza, C.S.P. Lima, P. Tanaka, Ilana Zalcberg, Ludmilla Oliveira
Publikováno v:
Clinical Lymphoma and Myeloma. 9:S78-S79
Autor:
Vania Hungria, Manuella Sampaio, Roberto Pinto Paes, Igor Campos, Adriana Quero, Flavia Parra, Carlos S. Chiattone, Ana Lucia Peres, Eliana C M Miranda, Edvan de Queiroz Crusoe
Publikováno v:
Blood. 118:5095-5095
Abstract 5095 Introduction – Multiple myeloma (MM) is a plasma cell dyscrasias characterized by the bone destruction, renal insufficiency, anemia and hypercalcemia. Studies suggest that the disease activity and the degree of angiogenesis in the bon
Autor:
Dorotea Fantl, Flavia Parra, Angelo Maiolino, Carlos S. Chiattone, Daniel Mercante, James Maciel, Adriana Quero, Vania Hungria, Edvan de Queiroz Crusoe, Ana Lucia Peres, Eliana C M Miranda, Rosane Bittencourt, Manuella Sampaio
Publikováno v:
Blood. 118:5117-5117
Abstract 5117 Background- Thalidomide (Thal) is a pro-apoptotic, immunoregulatory and antiangiogenic agent for MM. Although it is used since the 90's, the optimal combined treatment remains inconclusive. This is a preliminary analysis of the first La
Autor:
I. Zalcberg, Vania Tiestsche de Moraes Hungria, P. Tanaka, Luciene Da Cruz Oliveira, Adriana Quero, Jc Barros, C.S.P. Lima, Gislaine Oliveira-Duarte, A Maiolino, AL Miguel Peres, RP Magalhães, Eduardo Magalhães Rego, M. Nucci, Ecm Miranda, E. Braggio, Mercante, Irene Lorand-Metze, Carmino Antonio De Souza
Publikováno v:
Blood. 112:3703-3703
Introduction: Autologous stem cell transplantation (ASCT) remains the mainstay of treatment of multiple myeloma (MM) in patients Methods: From October 2003 to July 2008, 212 untreated patients induction with 3–5 cycles of VAD; high-dose cyclophosph
Autor:
Erika Coelho, Karina Antero Rosa Ribeiro, Luciana Camargo de Oliveira, Vania Hungria, Adriana Quero, Lais Rocha, Gracia Martinez, Gisele W. B. Colleoni, Angelo Maiolino, Rosane Bittencourt
Publikováno v:
Blood. 106:5069-5069
Introduction: The survival of patients with multiple myeloma varies from a few months to more than 10 years. This heterogeneity is related to the characteristics of the myeloma itself and of the host. The identification of the factors which influence